Long-Term Survival Outcomes of Elderly Patients Treated With S-1 or Capecitabine Plus Oxaliplatin for Stage II or III Gastric Cancer: A Multicenter Cohort Study.

Seohee Choi Jae-Seok Min Chi-Young Jeong Moon-Won Yoo Young Gil Son Sung Jin Oh Jong-Han Kim Joong-Min Park Hoon Hur Ye Seob Jee Sun-Hwi Hwang Sung-Ho Jin Sang Eok Lee Young Joon Lee Kyung Won Seo Sungsoo Park Chang-Min Lee Chang Hyun Kim In Ho Jeong Han-Hong Lee Sung Il Choi Sang-Il Lee Chan-Young Kim Hyundong Chae Myoung-Won Son Kyung Ho Pak Sungsoo Kim Moon-Soo Lee Hyoung Il Kim

Published in: Journal of gastric cancer (2022)

This multicenter observational cohort study found significant differences in RFS and OS between S-1 and CAPOX AC among patients with gastric cancer aged ≥70 years.

Keyphrases

cross sectional
double blind
middle aged

phase ii study
locally advanced
randomized controlled trial

community dwelling
metastatic breast cancer
radiation therapy

phase iii
adipose tissue
glycemic control